Montag, 01.06.2020 03:07 Uhr

Covid-19 vaccine, Italian research

Verantwortlicher Autor: Giorgio Esposito EN, 18.04.2020, 20:06 Uhr
Presse-Ressort von: GIORGIO ESPOSITO Bericht 4092x gelesen
Covid-19 world very danger
Covid-19 world very danger  Bild: O.M.S.

EN [ENA] The fight against the deadly coronavirus that has now appeared in all the countries of the world continues unabated and the World Health Organization itself hopes and supports the search for vaccines first and treatments afterwards to eradicate "the black plague "of the third millennium.

On December 31, 2019, WHO was informed of numerous cases of unknown cause pneumonia found in the city of Wuhan in the Chinese province of Hubei. Local authorities identified SARS-CoV-2 as a causal virus on January 7, 2020 and the disease was named coronavirus disease 2019 (COVID-19) by WHO on February 11, 2020. WHO's response was immediate. outbreak of cases, with a search (R &S) activated to accelerate the development of diagnostics, vaccines and therapies for this new coronavirus. Precisely for this reason, under the coordination of the WHO, a group of experts with different backgrounds is working on the development of vaccines against COVID-19.

The deepening -Scientific history shows that the time between the formulation of a vaccine and the placing on the market is at least a year, but SARS CoV2 (virus responsible for COVID -19) is part of a family of viruses, that of Coronaviruses, already known, characterized and widely studied at the time of the SARS or avian epidemic of 2002.The imposed lockdown will help stem the spread of the pandemic by avoiding the collapse of the health system, but the solution to the problem is in "flock immunity".

The vaccine is constructed using a non-dangerous version of an adenovirus: a virus that can cause a common cold-like illness. The adenovirus has been modified so as not to reproduce in our body and inserting the genetic code necessary for the production of the 'Spike' protein of the coronavirus into the adenoviral genome, in order to allow the adenovirus to express this protein in following the administration of the vaccine.This involves the production of antibodies against the 'Spike' protein found on the surface of the coronaviruses. In vaccinated individuals, antibodies produced against the 'Spike' protein can bind to the coronavirus that has entered the human body and prevent it from causing an infection.

Für den Artikel ist der Verfasser verantwortlich, dem auch das Urheberrecht obliegt. Redaktionelle Inhalte von European-News-Agency können auf anderen Webseiten zitiert werden, wenn das Zitat maximal 5% des Gesamt-Textes ausmacht, als solches gekennzeichnet ist und die Quelle benannt (verlinkt) wird.
Zurück zur Übersicht